News

Solaris Progresses with Warintza Project to Unlock Copper Potential

Solaris Progresses with Warintza Project to Unlock Copper Potential

Solaris Achieves Significant Milestones in Warintza Project

HIGHLIGHTS:

  • Completion of Extensive Drilling Campaign
    • In total, 82,000 metres of infill drilling have been accomplished
    • Mineral Resource Estimate update is anticipated for 2025
    • Ongoing exploration activities are set to uncover more potential
  • Environmental Impact Assessment Technical Approval Target
  • Upcoming Pre-Feasibility Study Expected in 2025
  • Political Transition Brings Stability to Operations

Solaris Resources Inc. is thrilled to announce the successful completion of a notable drilling campaign at the Warintza Project. This project, situated in a promising area, represents a cornerstone for the company.

Over the past year, Solaris has achieved remarkable progress by executing more than 82,000 metres of infill drilling. The results from this extensive effort will allow the company to significantly upgrade its Inferred Resources to the more prestigious Measured and Indicated categories, a strategic move that enhances the project’s economic viability. An updated Mineral Resource Estimate is expected in 2025, and this data will pave the way for detailed economic studies, bringing Warintza closer to development.

In addition to the infill drilling, more than 15,000 metres have been dedicated to geotechnical, hydrogeological, and metallurgical inquiries, essential for the comprehensive technical analyses that support the project.

Unlocking Value Across the Warintza Copper Project

To date, Solaris has drilled an impressive total of over 200,000 metres across both the Warintza Central and East porphyries. This wealth of information is pivotal in developing a flexible and staged mine plan that emphasizes near-surface mineralization, a crucial factor for reducing initial capital expenditures. Furthermore, these improved geological insights allow for a better understanding of the mine's overburden to ore characteristics, ensuring efficient long-term operations.

While Warintza is set to transform into a premier multigenerational copper project, Solaris is simultaneously focused on unlocking further value from its extensive 100%-owned land package exceeding 260 km², which includes several high-priority exploration targets. Active field exploration continues to unveil more opportunities for growth.

Infrastructure Development and Political Stability

On the infrastructure side, Solaris has made significant strides by completing 20 kilometres of internal road access, which enhances the project's feasibility by allowing year-round access. This development not only accelerates timelines but also plays a critical role in cost management during the construction phase, a vital advantage as the company gears towards development.

The recent political stability brought about by the re-election of President Daniel Noboa has further reinforced the environment conducive to mining operations. Solaris has made substantial progress in permitting and engaging with various stakeholders, working closely with Ecuador’s Ministries of Environment and Mines on the Environmental Impact Assessment (EIA), with approval expected in the mid-2020s.

Progressing Towards Feasibility and Sustainable Mining

In tandem with environmental assessments, the company is advancing its Pre-Feasibility Study (PFS) under the expertise of Ausenco and Knight Piésold, with targeted completion in 2025. Following this, the project will transition into a Bankable Feasibility Study, culminating in a well-structured and financeable development plan.

Solaris is deeply committed to participatory mining, nurturing robust partnerships with local communities, and ensuring that sustainable practices guide all operations. The adherence to these principles not only protects community interests but also supports long-term value creation for all stakeholders involved.

With ongoing advancements in technical, environmental, and social sectors, Solaris has set its sights on delivering a Final Investment Decision (FID) by late 2026. This milestone aligns perfectly with an optimistic outlook for the global copper market, ensuring that the company is well-positioned for future success.

Matthew Rowlinson, President and CEO, remarked on the prospects ahead: “Ecuador’s bright future is within reach, and we are excited to work collaboratively with the government to tap into the vast potential offered by the Warintza Copper Project. This endeavor is more than a mining operation; it’s an opportunity for sustainable growth and development.”

Rowlinson added, “Warintza is a testament to what responsible development can accomplish. Our core mission is to operate with integrity, empower communities, and generate lasting benefits for all stakeholders involved.”

For Further Information

For more insights and details, interested parties can contact Patrick Chambers, VP Investor Relations.

Email: pchambers@solarisresources.com

Frequently Asked Questions

What milestones has Solaris achieved in the Warintza Project?

Solaris has completed over 82,000 metres of drilling, advanced the Environmental Impact Assessment, and is preparing a Pre-Feasibility Study.

What is the significance of the recent drilling campaign?

This campaign aims to upgrade Inferred Resources to Measured and Indicated categories, which are crucial for detailed economic studies.

How is Solaris addressing infrastructure challenges?

By completing 20 kilometres of internal road access, Solaris significantly improves project accessibility, reducing costs and accelerations timelines.

What role does political stability play in Solaris's operations?

The re-election of President Noboa bolsters the supportive policy environment, essential for permitting and stakeholder engagement.

What is Solaris's commitment to sustainable mining?

Solaris focuses on participatory mining, involving local communities and fostering responsible development practices that benefit stakeholders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading